GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Binex Co Ltd (XKRX:053030) » Definitions » Cyclically Adjusted Revenue per Share

Binex Co (XKRX:053030) Cyclically Adjusted Revenue per Share : ₩0.00 (As of Mar. 2024)


View and export this data going back to 2001. Start your Free Trial

What is Binex Co Cyclically Adjusted Revenue per Share?

Note: As Cyclically Adjusted Revenue per Share is a main component used to calculate Cyclically Adjusted PS Ratio. If the month end stock price for this stock is zero, result may not be accurate due to the exchange rate between different shares and the data will not be stored into our database. Selected historical data showed in the calculation section below is only for demostration purpose.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Binex Co's adjusted revenue per share for the three months ended in Mar. 2024 was ₩960.729. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is ₩0.00 for the trailing ten years ended in Mar. 2024.

During the past 12 months, Binex Co's average Cyclically Adjusted Revenue Growth Rate was 8.30% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 8.00% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 6.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Binex Co was 8.00% per year. The lowest was 1.30% per year. And the median was 4.00% per year.

As of today (2024-05-20), Binex Co's current stock price is ₩16060.00. Binex Co's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 was ₩0.00. Binex Co's Cyclically Adjusted PS Ratio of today is .

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Binex Co was 10.59. The lowest was 1.89. And the median was 3.83.


Binex Co Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for Binex Co's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Binex Co Cyclically Adjusted Revenue per Share Chart

Binex Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3,019.29 3,107.88 3,245.12 3,613.75 3,914.77

Binex Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3,738.45 3,795.19 3,860.52 3,914.77 -

Competitive Comparison of Binex Co's Cyclically Adjusted Revenue per Share

For the Biotechnology subindustry, Binex Co's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Binex Co's Cyclically Adjusted PS Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Binex Co's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Binex Co's Cyclically Adjusted PS Ratio falls into.



Binex Co Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Binex Co's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=960.729/118.8477*118.8477
=960.729

Current CPI (Mar. 2024) = 118.8477.

Binex Co Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201406 629.631 99.353 753.175
201409 591.601 99.608 705.871
201412 572.660 99.098 686.788
201503 555.198 99.720 661.693
201506 571.480 100.050 678.851
201509 617.009 100.110 732.495
201512 678.479 100.220 804.587
201603 656.408 100.560 775.781
201606 621.051 100.790 732.320
201609 696.837 101.460 816.257
201612 678.006 101.560 793.417
201703 695.337 102.850 803.492
201706 632.551 102.610 732.650
201709 636.626 103.490 731.100
201712 496.505 102.990 572.953
201803 725.753 104.100 828.569
201806 769.802 104.130 878.606
201809 850.895 105.650 957.188
201812 996.362 104.350 1,134.790
201903 937.145 104.490 1,065.916
201906 1,022.440 104.880 1,158.606
201909 975.165 105.200 1,101.674
201912 1,069.430 105.120 1,209.088
202003 1,007.747 105.540 1,134.815
202006 1,091.607 104.870 1,237.103
202009 1,060.435 106.200 1,186.726
202012 1,124.538 105.765 1,263.634
202103 1,047.222 107.357 1,159.307
202106 916.095 107.579 1,012.058
202109 506.116 108.759 553.063
202112 1,285.937 109.676 1,393.469
202203 1,143.354 111.806 1,215.366
202206 1,305.143 114.083 1,359.655
202209 1,276.921 114.831 1,321.583
202212 1,336.503 115.200 1,378.820
202303 1,558.621 116.550 1,589.354
202306 1,213.076 117.140 1,230.762
202309 971.091 119.111 968.943
202312 1,147.514 118.848 1,147.514
202403 960.729 118.848 960.729

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


Binex Co  (XKRX:053030) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Binex Co was 10.59. The lowest was 1.89. And the median was 3.83.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Binex Co Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of Binex Co's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Binex Co (XKRX:053030) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Binex Co Ltd (XKRX:053030) » Definitions » Cyclically Adjusted Revenue per Share
Traded in Other Exchanges
N/A
Address
480-2 Janglim-dong, Saha-gu, Busan, KOR, 604-846
Binex Co Ltd is engaged in manufacturing and distribution of pharmaceutical products. The key products include gastrointestinal (GI) tract regulators and antispasmodics, antiemetic drugs, antihistamines, laxatives, antihypertensive and urinary agents, antibacterial and antibiotic agents, cough and cold remedies, anti-diabetic medicines, ophthalmic solutions, vitamins, nutrients, as well as an ointment, creams, and others. It also manufactures biomedicines and raw materials. Its other business operation involved contract development and manufacturing business for other companies. The company invests in some bio ventures that develop biomedicines.

Binex Co (XKRX:053030) Headlines

No Headlines